Dr. Rajesh Rajpal, MD, Global Head of Clinical and Medical Affairs, Johnson & Johnson Vision discusses the launch and availability of their TECNIS Synergy™ in the United States and Canada. This next-generation presbyopia-correcting intraocular (PC-IOL) lens offers cataract patients the widest range of continuous vision, and best near vision among leading PC-IOLs, without the visual gaps seen with some multifocal technology. He talks about how this new next-gen lens was developed, designed, and the science behind it, as well as other innovations in eye care solutions.
Rajesh Rajpal, M.D. is Chief Medical Officer and Global Head of Clinical and Medical Affairs for Johnson & Johnson Vision. In this role, Dr. Rajpal leads the integration of rapidly evolving medical and clinical insights into new product development to address unmet needs of patients and eye care professionals around the world. He also oversees clinical trials and the generation of surgical and vision care evidence and serves as the critical liaison to government agencies and to the academic, scientific, and industry communities.
Dr. Rajpal joined Johnson & Johnson Vision in 2020 from Avedro (acquired by Glaukos), where he served as Chief Medical Officer. He was a member of the senior executive team that led to an IPO and subsequent acquisition and directly oversaw clinical operations, medical affairs, regulatory affairs, and professional relations for professional societies and clinicians.
Active in research and professional education, Dr. Rajpal has served as principal investigator in numerous clinical trials, authored multiple original peer-reviewed publications and textbook chapters, and has lectured internationally on topics related to corneal disease, cataract and refractive surgery. In addition to others, he is a recipient of the Senior Achievement and Secretariat awards from the American Academy of Ophthalmology.
He currently holds appointments on the clinical faculties of Georgetown University Medical Center and Virginia Commonwealth University and serves as the Cornea Consultant to the Walter Reed National Military Medical Center. He is certified by and is a Diplomate of the American Board of Ophthalmology. He is a member of the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery, Cedars/Aspens, AECOS, and the International Society of Refractive Surgery. Additionally, he has served as President and on the Board of Directors of the Washington D.C. Ophthalmology Society.
He is the founder of the See Clearly Vision Group, an ophthalmology and optometry group practice with multiple offices in the metropolitan Washington, DC area. Dr. Rajpal has been regularly recognized as a Top Doctor by Washingtonian Magazine, Northern Virginia Magazine, and Consumers’ Research Council of America. He was the first eye surgeon in Washington, D.C. to perform Laser Vision Correction as part of the clinical trials for FDA approval.